CENTRAL VEIN OCCLUSION STUDY -- PARTICIPATING CENTER
中央静脉闭塞研究——参与中心
基本信息
- 批准号:3559390
- 负责人:
- 金额:$ 16.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-03-01 至 1994-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This application is for a participating center of a national
collaborative randomized controlled clinical trial of
photocoagulation treatment for central vein occlusion. The study
will be conducted at 8 clinical centers with the Reading Center at
the Bascom Palmer Eye Institute (University of Miami), and the
Coordinating Center at Scott and White Hospital in Temple, Texas
(Texas A&M University). Patients will be entered into four study
groups: Non-perfused (Group N); Macular edema (Group M);
Perfused (Group P); and Indeterminant (Group I). Eyes in the first
two groups will be randomly assigned to photocoagulation
treatment and a control group. Patients in Groups P and I will be
followed for natural history and for possible later entry into the
randomized study. Estimated recruitment is 240 patients in
Group N; 480 in Group P and 240 in Group I. Approximately 50%
of these patients will also qualify for Group M. Patients will be
recruited for the first 3 years of this 5 year study, and all patients
will be followed until termination of the study. The study is
designed to provide information regarding whether or not
photocoagulation is efficacious in preventing neovascular
glaucoma in eyes with central vein occlusion and retinal non-
perfusion, and whether or not photocoagulation is useful in
preserving visual acuity in eyes with central vein occlusion and
macular edema. Information collected at base line and each
follow-up visit will be forwarded to the Coordinating Center for
processing and analysis. Photographs will be reviewed at the
Reading Center to ascertain eligibility and adequacy of
treatment. A Data Monitoring Committee will review interim
results of the study every 6 months.
此申请是针对某国家的参与中心
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL FINKELSTEIN其他文献
DANIEL FINKELSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL FINKELSTEIN', 18)}}的其他基金
RETINAL THICKNESS ANALYSIS OF CYCLIC VISUAL ACUITY CHANGES IN MACULAR EDEMA
黄斑水肿周期性视力变化的视网膜厚度分析
- 批准号:
6218274 - 财政年份:1998
- 资助金额:
$ 16.82万 - 项目类别:
RETINAL THICKNESS ANALYSIS OF CYCLIC VISUAL ACUITY CHANGES IN MACULAR EDEMA
黄斑水肿周期性视力变化的视网膜厚度分析
- 批准号:
6297545 - 财政年份:1998
- 资助金额:
$ 16.82万 - 项目类别:
RETINAL THICKNESS ANALYSIS OF CYCLIC VISUAL ACUITY CHANGES IN MACULAR EDEMA
黄斑水肿周期性视力变化的视网膜厚度分析
- 批准号:
6114363 - 财政年份:1998
- 资助金额:
$ 16.82万 - 项目类别:
RETINAL THICKNESS ANALYSIS OF CYCLIC VISUAL ACUITY CHANGES IN MACULAR EDEMA
黄斑水肿周期性视力变化的视网膜厚度分析
- 批准号:
6275598 - 财政年份:1997
- 资助金额:
$ 16.82万 - 项目类别:
CENTRAL VEIN OCCLUSION STUDY -- PARTICIPATING CENTER
中央静脉闭塞研究——参与中心
- 批准号:
3559389 - 财政年份:1988
- 资助金额:
$ 16.82万 - 项目类别:
CENTRAL VEIN OCCLUSION STUDY -- PARTICIPATING CENTER
中央静脉闭塞研究——参与中心
- 批准号:
3559388 - 财政年份:1988
- 资助金额:
$ 16.82万 - 项目类别:
CENTRAL VEIN OCCLUSION STUDY -- PARTICIPATING CENTER
中央静脉闭塞研究——参与中心
- 批准号:
3551879 - 财政年份:1988
- 资助金额:
$ 16.82万 - 项目类别:
MULTICENTER BVOS: MACULAR EDEMA DATA ANALYSIS
多中心 BVOS:黄斑水肿数据分析
- 批准号:
3262153 - 财政年份:1985
- 资助金额:
$ 16.82万 - 项目类别:
相似海外基金
From lymphatics to evaluating resolution therapeutics in clinical trials
从淋巴管到评估临床试验中的解决疗法
- 批准号:
MR/Y013050/1 - 财政年份:2024
- 资助金额:
$ 16.82万 - 项目类别:
Fellowship
RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network
RareKids-CAN:儿科罕见病临床试验和治疗网络
- 批准号:
495575 - 财政年份:2023
- 资助金额:
$ 16.82万 - 项目类别:
Operating Grants
Unbiased estimation in hierarchical models for Clinical trials
临床试验分层模型中的无偏估计
- 批准号:
2884930 - 财政年份:2023
- 资助金额:
$ 16.82万 - 项目类别:
Studentship
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 16.82万 - 项目类别:
NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
- 批准号:
10855627 - 财政年份:2023
- 资助金额:
$ 16.82万 - 项目类别:
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES
CCTN-避孕发展计划-NICHD避孕临床试验网络-女性站点-核心功能活动
- 批准号:
10895949 - 财政年份:2023
- 资助金额:
$ 16.82万 - 项目类别:
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CCTN - FEMALE SITES 'CORE FUNCTION ACTIVITIES
避孕临床试验网络,CCTN - 女性站点的核心功能活动
- 批准号:
10891325 - 财政年份:2023
- 资助金额:
$ 16.82万 - 项目类别:
ISimcha Technology Platform for Recruiting a Diverse Population of Older Adults into Clinical Trials
ISimcha 技术平台,用于招募不同的老年人群进行临床试验
- 批准号:
10761602 - 财政年份:2023
- 资助金额:
$ 16.82万 - 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
- 批准号:
10758129 - 财政年份:2023
- 资助金额:
$ 16.82万 - 项目类别:














{{item.name}}会员




